Novel Models for Licensing of Software, Content and Data

Novel Models for Licensing of Software, Content and Data

Date: June 30, 2022 (Thursday)
Time: Noon – 1:15 PM (Eastern)
Cost: Members: $150, Non-Members: $225

Universities licensing software, content and data must overcome many issues, including providing support services, navigating Unrelated Business Income (UBI) and Private Business Use (PBU), following state laws prohibiting certain commercialization activities, and complying with data privacy laws. This session will explore novel, innovative and validated licensing models that address these challenges. Those new models include partnerships with local subject matter experts to provide service, joint IP development and commercialization models, digital platforms for dissemination, and dual licensing. We'll also cover licensing of clinical data.

Learning Objectives
  • Understand the possible issues associated with licensing data, software and content
  • Leverage new models of licensing for software, data, and content
  • Describe how these new models address issues and mitigate risks
Speakers Speaker Bios

Daniel Dardani, CLP
Director of Physical Sciences and Digital Innovation Licensing and Corporate Alliances
Duke University

After nineteen years at MIT's Technology Licensing Office, Daniel Dardani is now at Duke University's Office of Translation and Commercialization where he's at the forefront of intellectual property licensing and technology entrepreneurship. His chief focus is outreach, marketing, and licensing of physical sciences and digital innovations, and leveraging translational funds for investments in nascent technologies. Dan also provides strategic support for developing multi-year corporate alliances, establishing new corporate partners, and negotiating IP terms for significant sponsored research agreements.

Dan’s IP expertise spans patents, copyrights, trademarks, corporate license negotiations and patent portfolio monetization strategies. â€‹His skills are well-suited for translating research and technology into business and industry commercialization opportunities.

Dinesh Divakaran, PhD
Regional Vice President of Partnerships, North America
Owkin

Dinesh Divakaran is Regional Vice President of Partnerships, North America with Owkin. In this role, he leads RWD partnerships and collaborations for the french-american unicorn with the healthcare ecosystem across North America. Dinesh has fifteen years  of business development experience in building partnerships, fostering innovation, commercializing technologies and developing ventures. Prior to joining Owkin, Dinesh was Vice President of Healthcare Business Development, North America at Sensyne Health plc. Before this, he worked as Director of Digital Innovations with the Office for Translation & Commercialization at Duke Health and Duke University. At Duke, Dinesh led the commercialization of digital innovations and data assets through licensing, spinouts and collaborations. He also sat on the boards of three startups, had a short stint in venture capital as a fellow at Alumni Ventures and over several years has reviewed SBIR/STTR grant proposals as a panelist at NIH and NSF. Preceding Duke, Dinesh worked in technology commercialization and venture development at North Carolina State University, Texas A&M University System and University of South Florida. He has also served on the Forbes Business Development Council, innovation committee at HIMSS and cloud services & software committee at LES (USA & Canada). Currently an Executive in Residence with the Duke Institute of Health Innovation, Dinesh received his PhD in Electrical Engineering from the University of South Florida and his MBA from North Carolina State University.

Questions?
Just email Sammi Spiegel, AUTM Professional Development, or call +1-202-960-1791.